Posts

Showing posts with the label Export of injection Remdesivir

What is the role of the antiviral drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19)?

Image
  What is the role of the antiviral drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19)? Remdesivir  (Veklury) was the first drug approved by the FDA for treating the SARS-CoV-2 virus. It is indicated for treatment of COVID-19 disease in hospitalized adults and children aged 12 years and older who weigh at least 40 kg. The broad-spectrum antiviral is a nucleotide analog prodrug.  [ 21 ]  Full approval was preceded by the US FDA issuing an EUA (emergency use authorization) on May 1, 2020 to allow prescribing remdesivir for severe COVID-19 (confirmed or suspected) in hospitalized adults and children.  [ 155 ]  Upon approval of remdesivir in adults and adolescents, the EUA was updated to maintain the ability for prescribers to treat pediatric patients weighing 3.5 kg to less than 40 kg or children younger than 12 years who weigh at least 3.5 kg. What is the role of nitazoxanide in the treatment of coronavirus disease 2019 (COVID-2019)? What...

As Covid cases rise, Taj Pharmaceuticals to scale up Remdesivir production at Daman Site

Image
 As Covid cases rise, Taj Pharma to scale up Remdesivir production Companies like Cipla, Mylan, Jubilant Life Sciences,Taj Pharma, Hetero Drugs, Syngene International and Dr Reddy’s Laboratories are also manufacturing Remdesivir for the Indian market. Following the surge in cases of Covid-19, pharma major Taj Pharmaceuticals Ltd., (Taj Pharma) is scaling up production capacity of Remdesivir injections, which are used to treat coronavirus patients. Taj Pharma has an installed capacity to make eight lakh doses of Remdesivir per month. Sources in the Taj Pharma group said that in the coming days, the installed capacity will be increased up to 12 lakh doses per month at its  Daman plant. In the last 24 hours, more than 4,000 new Covid-19 cases have been reported in Gujarat. The total number of cases in the state has crossed 3,32,500 as of Friday evening since the outbreak of the pandemic. There are around 20,500 active cases. Dr Reddy’s Laboratories has launched the generic drug R...